Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GNAS1 mutational analysis in pseudohypoparathyroidism

S F Ahmed1, P H Dixon, D T Bonthron

  • 1MRC Molecular Endocrinology Group, Imperial College School of Medicine, Hammersmith Hospital London, UK.

Clinical Endocrinology
|January 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023.

Endocrine connections·2026
Same author

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey.

Endocrine connections·2024
Same author

Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol.

Endocrine connections·2023
Same author

Electronic reporting of rare endocrine conditions within a clinical network: results from the EuRRECa project.

Endocrine connections·2023
Same author

The I-CAH Registry: A platform for international collaboration for improving knowledge and clinical care in congenital adrenal hyperplasia.

Clinical endocrinology·2023
Same author

Hypoxia stimulates angiogenesis and a metabolic switch in human parathyroid adenoma cells.

Endocrine oncology (Bristol, England)·2023

GNAS1 gene mutations are found in about half of pseudohypoparathyroidism type Ia (PHPIa) cases, but not in pseudopseudohypoparathyroidism (PPHP) alone. Single-stranded conformational polymorphism (SSCP) effectively detects these GNAS1 mutations.

Area of Science:

  • Genetics
  • Molecular Biology
  • Endocrinology

Background:

  • Mutations in the GNAS1 gene, encoding the alpha-subunit of the stimulatory GTP-binding protein, are linked to pseudohypoparathyroidism type Ia (PHPIa) and pseudopseudohypoparathyroidism (PPHP).
  • Understanding the prevalence and detection methods for GNAS1 mutations is crucial for diagnosing and managing these disorders.

Purpose of the Study:

  • To determine the prevalence of GNAS1 mutations in families with PHPIa and PPHP.
  • To evaluate single-stranded conformational polymorphism (SSCP) as a rapid detection method for GNAS1 mutations.

Main Methods:

  • Investigated 13 unrelated families (8 with PHPIa/PPHP, 5 with PPHP only) for GNAS1 mutations.
  • Analyzed the 1050 bp region spanning exons 2-13 using SSCP and DNA sequencing.

Related Experiment Videos

Main Results:

  • GNAS1 mutations were identified in 4 of 8 families with PHPIa, including two novel missense mutations and an identical 4 bp deletion causing a frame-shift in two unrelated families.
  • A mutational hot-spot involving codons 189 and 190 was confirmed.
  • SSCP analysis demonstrated high specificity and sensitivity, detecting all identified mutations.
  • No GNAS1 mutations were found in families with PPHP only.

Conclusions:

  • GNAS1 mutations are the molecular cause in approximately 50% of PHPIa cases, highlighting genetic heterogeneity.
  • SSCP is a reliable method for identifying GNAS1 mutations, aiding clinical evaluation, especially in cases of incomplete penetrance.